Matches in Wikidata for { <http://www.wikidata.org/entity/Q94557566> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q94557566 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q94557566 description "scientific article published on 08 May 2020" @default.
- Q94557566 description "wetenschappelijk artikel" @default.
- Q94557566 description "наукова стаття, опублікована 8 травня 2020" @default.
- Q94557566 name "Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United States" @default.
- Q94557566 name "Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United States" @default.
- Q94557566 type Item @default.
- Q94557566 label "Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United States" @default.
- Q94557566 label "Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United States" @default.
- Q94557566 prefLabel "Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United States" @default.
- Q94557566 prefLabel "Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United States" @default.
- Q94557566 P1433 Q94557566-F0C17B55-BC8A-4EDA-9E27-7F138A444781 @default.
- Q94557566 P1476 Q94557566-AA63B911-3566-4B44-9EC7-1B450936E581 @default.
- Q94557566 P2093 Q94557566-0BBC62DE-8AAB-48C2-B316-95F65B9C7255 @default.
- Q94557566 P2093 Q94557566-0F692980-AF87-414A-B8E6-0D0BD5646B1F @default.
- Q94557566 P2093 Q94557566-2273D975-F275-4A49-809F-2250B5BE38A6 @default.
- Q94557566 P2093 Q94557566-455EDE8A-125A-44A0-A165-22EA2DB4D00D @default.
- Q94557566 P2093 Q94557566-605DF36D-2E19-4FE9-935B-79F5F9313D31 @default.
- Q94557566 P2093 Q94557566-8A3B18A1-567D-4C8B-B0E3-C33B3D5017CA @default.
- Q94557566 P2093 Q94557566-8BC82A14-3AEB-4F51-ACBC-73A810371AB2 @default.
- Q94557566 P2093 Q94557566-DF70EA4B-4A60-43A6-B2BC-1112DB746336 @default.
- Q94557566 P2093 Q94557566-F3EC22FB-F40D-4203-A7FF-F881189BD91B @default.
- Q94557566 P2093 Q94557566-FEBFCE68-4C56-45BB-B0D6-07A2F0184085 @default.
- Q94557566 P31 Q94557566-1BE05C83-806A-4694-9BFD-FCF0583C6DDB @default.
- Q94557566 P356 Q94557566-AC4E24FE-C52E-4B11-8B44-D1F49604C803 @default.
- Q94557566 P50 Q94557566-AE99AAC6-56FD-4A0B-B4EE-E498F8343913 @default.
- Q94557566 P577 Q94557566-1AB97CCF-E97E-49B6-9B66-B88C35069773 @default.
- Q94557566 P698 Q94557566-7CA47F1A-B531-457E-9D11-E57A0FBB6EB0 @default.
- Q94557566 P921 Q94557566-4604EB9C-C58C-44BA-A089-866D9DBF65B6 @default.
- Q94557566 P356 S40273-020-00919-1 @default.
- Q94557566 P698 32383129 @default.
- Q94557566 P1433 Q7180778 @default.
- Q94557566 P1476 "Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United States" @default.
- Q94557566 P2093 "Arliene Ravelo" @default.
- Q94557566 P2093 "Hélène Parisé" @default.
- Q94557566 P2093 "Kavita R Sail" @default.
- Q94557566 P2093 "Matthew S Davids" @default.
- Q94557566 P2093 "Sang Kyu Cho" @default.
- Q94557566 P2093 "Scott Johnson" @default.
- Q94557566 P2093 "Sheila Shapouri" @default.
- Q94557566 P2093 "Simon Sharmokh" @default.
- Q94557566 P2093 "Suchin Virabhak" @default.
- Q94557566 P2093 "Tatyana Kapustyan" @default.
- Q94557566 P31 Q13442814 @default.
- Q94557566 P356 "10.1007/S40273-020-00919-1" @default.
- Q94557566 P50 Q94557564 @default.
- Q94557566 P577 "2020-05-08T00:00:00Z" @default.
- Q94557566 P698 "32383129" @default.
- Q94557566 P921 Q1088156 @default.